CoraLite® Plus 488-conjugated CYP7B1 Recombinant antibody

CYP7B1 Recombinant Antibody for IF/ICC
Cat No. CL488-82927
Clone No.230160H5

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

IF/ICC

Formulation:  PBS and Azide
PBS and Azide
Conjugate:  CoraLite® Plus 488
Size/Concentration: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:


Tested Applications

Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

CL488-82927 targets CYP7B1 in IF/ICC applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Recombinant
Type Antibody
Immunogen CYP7B1 fusion protein Ag19374 Predict reactive species
Full Name cytochrome P450, family 7, subfamily B, polypeptide 1
Calculated Molecular Weight 506 aa, 58 kDa
Observed Molecular Weight 50-55 kDa
GenBank Accession NumberBC136574
Gene Symbol CYP7B1
Gene ID (NCBI) 9420
RRIDAB_3673120
Conjugate CoraLite® Plus 488 Fluorescent Dye
Excitation/Emission Maxima Wavelengths493 nm / 522 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDO75881
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

CYP7B1(Cytochrome P450 7B1) is also named as 25-hydroxycholesterol 7-alpha-hydroxylase and belongs to the cytochrome P450 family. It catalyzes the first and rate-limiting step in the coonversion of cholesterol to bile acids and CYP7B1-mediated catalysis may play a role for control of the cellular levels of androgens, not only of estrogens.

Protocols

Product Specific Protocols
IF protocol for CL Plus 488 CYP7B1 antibody CL488-82927Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...